Zihai Li

44PUBLICATIONS
226CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markersMedical infection agents (incl. prions)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|May 20, 2026
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.

|Mar 28, 2026
ZFP148 is a transcriptional repressor of cytolytic effector CD8+ T cell differentiation.

Tong Xiao, Xingyu Chen, No-Joon Song

|Feb 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Sumithira Vasu, Nathan Denlinger, No-Joon Song

|Oct 30, 2025
Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion.

Haoxin Zhao, Jaeoh Park, Yuzhu Wang

|Oct 03, 2025
T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancer.

Johanna M Schafer, No-Joon Song, Tong Xiao

Pageof 8

Frequent Collaborators

11 joint publications

Qin Ma

9 joint publications

Anjun Ma

6 joint publications

Dongjun Chung

5 joint publications

No-Joon Song